Setting new standards for the pharmacological treatment of panic disorder

Human Psychopharmacology

Volumn 12, Issue SUPPL. 1, 1997, Pages

  Kumar, R ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Comparative studies; Long term; Panic disorder; Paroxetine; Treatment

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; CLOMIPRAMINE; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL TRIAL; COGNITIVE THERAPY; CONFERENCE PAPER; DRUG EFFICACY; DRUG TOLERABILITY; HEADACHE; NAUSEA; NONHUMAN; ORAL DRUG ADMINISTRATION; PANIC; PRIORITY JOURNAL; PSYCHOTHERAPY; QUALITY OF LIFE; SEXUAL DYSFUNCTION; SIDE EFFECT; SOMNOLENCE; XEROSTOMIA;

EID: 0030754558     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(199706)12:1+3.0.CO;2-X     Document Type: Conference Paper

References (13)

1. Alexander, P. E. and Alexander, D. D. (1986). Alprazolam treatment for panic disorders. Journal of Clinical Psychiatry, 47, 301-304.
2. American Psychiatric Association (1987). DSM-IIIR: Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, revised. APA, Washington.
3. Cassano, G. B., Petracca, A., Perugi, G., Nisita, C., Musetti, L., Mengali, F. and McNair, D. M. (1988). Clomipramine for panic disorder I: the first 10 weeks of a long-term comparison with imipramine. Journal of Affective Disorders, 14, 123-127.
4. Cookson, J. (1993). Side-effects of antidepressants. British Journal of Psychiatry, 163 (Suppl. 20), 20-24.
5. Dunbar, G. C., Steiner, M., Oakes, R., Gergel, I., Burnham, D. and Wheadon, D. E. (1995). A fixed dose study of paroxetine (10 mg, 20 mg, 40 mg) and placebo in the treatment of panic disorder. European Neuropsychopharmacology, 5, 361 (Abstract P5-26).
6. Johnson, J., Weissman, M. M. and Klerman, G. I. (1990). Panic disorder, comorbidity, and suicide attempts. Archives of General Psychiatry, 47, 805-808.
7. Judge, R. and Steiner, M. (1996). The long-term efficacy and safety of paroxetine in panic disorder. European Neuropsychopharmacology, 6 (Suppl. 3), 207.
8. Lecrubier, Y., Bakker, A., Dunbar, G., Judge, R. and Collaborative Paroxetine Panic Study Investigators (1997a). A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Acta Psychiatrica Scandinavica, 95, 145-152.
9. Lecrubier, Y., Judge, R. and Collaborative Paroxetine Panic Study Investigators (1997b). Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Acta Psychiatrica Scandinavica, 95, 153-160.
10. Oehrberg, S., Christiansen, P. E., Behnke, K., Borup, A. L., Severin, B., Soegaard, J., Calberg, H., Judge, R., Ohrstrom, J. K. and Manniche, P. M. (1995). Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study. British Journal of Psychiatry, 167, 374-379.
11. Salzman, C. (1993). Benzodiazepine treatment of panic and agoraphobic symptoms: use, dependence, toxicity, abuse. Journal of Psychiatric Research, 27 (Suppl.), 47-68.
12. Sheehan, D. V., Raj, B. A., Trehan, R. R. and Knapp, E. L. (1993). Serotonin in panic disorder and social phobia. International Journal of Clinical Psychopharmacology, 8 (Suppl. 2), 63-77.
13. Weissman, M. M., Klerman, G. L., Markowitz, J. S. and Ouellette, R. (1989). Suicide ideation and suicide attempts in panic disorder and attacks. New England Journal of Medicine, 321, 1209-1214.